$NBIX 8-K SEC Filings

Filed On	Filing
28 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On September 28, 2026, the Board of Directors (the “Board”) of Neurocrine Biosciences, Inc. (the “Company”) appointed Eiry W. Roberts, M.D., to succeed Sanjay Keswani, M.D., as the Company’s Chief Medical Officer, effective September 28,...
30 Jul 2026	8-K: Results of Operations and Financial Condition
28 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
18 May 2026	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +2 more
05 May 2026	8-K: Results of Operations and Financial Condition
06 Apr 2026	8-K: Entry into a Material Definitive Agreement
11 Feb 2026	8-K: Results of Operations and Financial Condition
24 Nov 2025	8-K: Departure/Election of Directors or Officers; Compensation
28 Oct 2025	8-K: Results of Operations and Financial Condition
30 Jul 2025	8-K: Results of Operations and Financial Condition
30 May 2025	8-K: Departure/Election of Directors or Officers; Compensation
22 May 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
05 May 2025	8-K: Results of Operations and Financial Condition
04 Apr 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
06 Feb 2025	8-K: Results of Operations and Financial Condition
27 Jan 2025	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
20 Dec 2024	8-K: Other Events
01 Nov 2024	8-K: Other Events
30 Oct 2024	8-K: Results of Operations and Financial Condition
11 Oct 2024	8-K: Departure/Election of Directors or Officers; Compensation

Comments